PMN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ProMIS Neurosciences Inc (PMN) is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock lacks significant positive catalysts, has weak financial performance, and no strong trading signals. It is better to hold off on investing in this stock until more favorable conditions or signals emerge.
The MACD is below 0 and negatively contracting, indicating a bearish trend. RSI is neutral at 37.282, suggesting no clear momentum. Moving averages are converging, showing no strong directional trend. The stock is trading below the pivot level (12.097), with support at 10.861 and resistance at 13.333.
No significant positive catalysts identified. The stock has a 70% chance to increase by 4.54% in the next week and 8.01% in the next month, but these are speculative and not guaranteed.
No recent news or events to drive positive sentiment. Financial performance is weak, with negative net income and EPS. No significant hedge fund or insider trading activity.
In Q4 2025, revenue remained at 0 with no growth. Net income increased to -10,674,088 (up 4381.01% YoY), but it is still negative. EPS improved to -4.14 (up 2487.50% YoY), but remains in the negative. Gross margin is 0, showing no profitability.
No analyst rating or price target changes available.
